Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - lamivudine 300 mg; abacavir sulfate 702,78 mg - eq. abacavir 600 mg - film-coated tablet - 600 mg - 300 mg - abacavir sulfate 702.78 mg; lamivudine 300 mg - lamivudine and abacavir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - lamivudine 300 mg/1 mg; abacavir sulfate 702,78 mg - eq. abacavir 600 mg - film-coated tablet - 600 mg - 300 mg - abacavir sulfate 702.78 mg; lamivudine 300 mg - lamivudine and abacavir

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - lamivudine 300 mg/1 mg; abacavir sulfate 702,78 mg - eq. abacavir 600 mg - film-coated tablet - 600 mg - 300 mg - abacavir sulfate 702.78 mg; lamivudine 300 mg - lamivudine and abacavir

United States - English - NLM (National Library of Medicine)

burel pharmaceuticals, llc - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. abacavir and lamivudine tablets are contraindicated in patients: • who have the hla-b*5701 allele [see warnings and precautions (5.1)]. • with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)] or lamivudine. • with moderate or severe hepatic impairment [see use in specific populations (8.7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir and lamivudine during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir or lamivudine compared with the background rate for birth defects of 2.7% in the metropolitan atl

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use

Malta - English - Medicines Authority

v.j. salomone pharma limited upper cross road, marsa mrs1542, malta - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

hetero labs limited - abacavir (sulfato) - abacavir (sulfato)....300.00 mg

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use

United States - English - NLM (National Library of Medicine)

avpak - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir tablet is contraindicated in patients: • who have the hla-b*5701 allele [see warnings and precautions ( 5.1)]. • with prior hypersensitivity reaction to abacavir [see warnings and precautions ( 5.1)]. • with moderate or severe hepatic impairment [see use in specific populations ( 8.6)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the background r

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

aurobindo pharma ltd. - abacavir (sulfato) - abacavir (sulfato)....600.00 mg / lamivudina....300.00 mg